NEW BACILLUS THURINGIENSIS STRAINS AND THEIR GENES ENCODING INSECTICIDAL TOXINS

Abstract: Two new Bacillus thuringiensis strains, which are deposited at the DSM under accession nos 5870 and 5871, produce new crystal proteins during sporulation that are toxic to Coleoptera and that are encoded by new genes. The crystal proteins contain protoxins, which can yield toxins as trypsin-digestion products. A plant, the genome of which is transformed with a DNA sequence that comes from either one of the strains and that encodes an insecticidally effective portion of its respective protoxin or encodes its respective toxin, is resistant to Coleoptera. Each strain, itself, or its crystals, crystal proteins, protoxin, toxin and/or insecticidally effective protoxin portion can be used as the active ingredient in an insecticidal composition for combatting Coleoptera.

Description: NEW BACILLUS THURINGIENSIS STRAINS AND THEIR GENES ENCODING INSECTICIDAL TOXINS This invention relates to two new strains of B. thuringiensis (the "BtI109P strain" and the » BtI260 strain") , each of which produces crystallized proteins (the "BtI109P crystal proteins" and the "BtI260 crystal proteins", respectively) which are packaged in crystals (the "BtI109P crystals" and the "BtI260 crystals", respectively) during sporulation. The BtI109P and BtI260 strains were deposited under the provisions of the Budapest Treaty at the Deutsche Sammlung Fur Mikroorganismen and Zellkulturen ("DSM"), Mascheroder Weg IB, D-3300 Braunschweig, Federal Republic of Germany, under accession numbers 5870 and 5871, respectively, on April 4, 1990. This invention also relates to an insecticide composition that is active against Coleoptera and that comprises the BtI109P or BtI260 strain, as such, or preferably the BtI109P or BtI260 crystals, crystal proteins or the active component(s) thereof as an active ingredient. This invention further relates to: 1) The "btI109P gene", from the genome of the BtI109P strain, which encodes an insecticidal protein (the "BtI109P protoxin") that is found in the BtI109P crystals; and 2) The "btI260 gene", from the genome of the BtI260 strain, which encodes an insecticidal protein (the "BtI260 protoxin") that is found in the BtI260 crystals. The BtI109P and BtI260 protoxins are the proteins that are produced by their respective BtI109P and BtI260 strains before being packaged into their respective BtI109P and BtI260 crystals. This invention still further relates to the "BtI109P toxin" and the "BtI260 toxin" which can be obtained (e.g., by trypsin digestion) from the BtI109P protoxin and the BtI260 protoxin, respectively. The BtI109P and BtI260 toxins are insecticidally active proteins which can be liberated from the BtI109P crystals and the BtI260 crystals, respectively, produced by the BtI109P strain and the BtI260 strain, respectively. Each toxin has a high activity against Coleoptera. The BtI109P and BtI260 toxins are believed to represent the smallest portions of their respective BtI109P and BtI260 protoxins which are insecticidally effective against Coleoptera. This invention yet further relates to a chimaeric gene that can be used to transform a plant cell and that contains: 1) a part of the btI109P or btI260 gene (the "insecticidally effective btI109P or btI260 gene part") encoding an insectidicidally effective portion of the respective BtI109P or BtI260 protoxin, preferably a truncated part of the btI109P or btI260 gene (the "truncated btI109P or btI260 gene") encoding just the respective BtI109P or BtI260 toxin; 2) a promoter suitable for transcription of the insecticidally effective btI109P or btI260 gene part in a plant cell; and 3) suitable 3' end transcript formation and polyadenylation signals for expressing the insecticidally effective btI109P or btI260 gene part in a plant cell. This chimaeric gene is hereinafter generally referred to as the "btI109P or btI260 chimaeric gene." Preferably, the insecticidally effective btI109P or btI260 gene part is present in the btll09P or btI260 chimaeric gene as a hybrid gene comprising a fusion of the truncated btI109P or btI260 gene and a selectable marker gene, such as the neo gene (the "btll09P-neo or btI260-neo hybrid gene") encoding a BtI109P-NPTII or BtI260-NPTII fusion protein. This invention also relates to: 1) a cell (the "transformed plant cell") of a plant, such as potato or corn, the nuclear genome of which is transformed with the insecticidally effective btI109P or btI260 gene part; and 2) a plant (the "transformed plant") which is regenerated from the transformed plant cell or is produced from the so-regenerated plant, the nuclear genome of which contains the insecticidally effective btI109P or btI260 gene part and which is resistant to Coleoptera. This invention still further relates to a B. thurinqiensis ("Bt") strain transformed, preferably by electroporation, with a vector carrying all or part of the btI109P or btI260 gene. Background of the Invention B. thurinqiensis ("Bt") is a gram-positive bacterium which produces endogenous crystals upon sporulation. The crystals are composed of proteins which are specifically toxic against insect larvae. Three different Bt pathotypes have been described: pathotype A that is active against Lepidoptera, e.g., caterpillars; pathotype B that is active against certain Diptera, e.g., osquitos and black flies; and pathotype C that is active against Coleoptera, e.g., beetles (Ellar et al, 1986). A Bt strain, whose crystals are toxic to Coleoptera, has been described as Bt tenebrionis (US patent 4,766,203; European patent publication ("EP") 149,162), as Bt M-7 or Bt San Diego (EP 213,818; U.S. patent 4,771,131) and as BtSl (European patent application ("EPA") 88402115.5). Two other strains toxic to Coleoptera, BtPGSI208 and BtPGSI245, have also been described (PCT publication WO 90/09445) . The fact that conventional submerged fermentation techniques can be used to produce Bt spores on a large scale makes Bt bacteria commercially attractive as a source of insecticidal compositions. Gene fragments from some Bt strains, encoding insecticidal proteins, have heretofore been identified and integrated into plant genomes in order to render the plants insect-resistant. However, obtaining expression of such Bt gene fragments in plants is not a straightforward process. To achieve optimal expression of an insecticidal protein in plant cells, it has been found necessary to engineer each Bt gene fragment in a specific way so that it encodes a water-soluble part of a Bt protoxin that retains substantial toxicity against its target insects (EPA 86300291.1 and EPA 88402115.5; U.S. patent application 821,582, filed January 22, 1986) . Summary of the Invention In accordance with this invention, the two new Bt strains of pathotype C, i.e., the BtI109P and BtI260 strains, are provided. The BtI109P and BtI260 crystals, crystal proteins, protoxins and toxins, produced by the respective strains during sporulation, as well as insecticidally effective portions of the BtI109P and BtI260 protoxins, each possess insecticidal activity and can therefore be formulated into insecticidal compositions against Coleoptera in general, especially against Aqelastica alni, Diabrotica luteola, Haltica tombacina, Anthonomus grandis, Tenebrio molitor, Diabrotica undecimpunctata , Triboleum castaneum, Dicladispa armiqera, Trichispa serica, Oulema oryzae, Colaspis brunnea, Lissorhorptrus oryzophilus, Phyllotreta cruciferae, Phyllotreta striolata, Psyl1iodes punctulata, Entomoscelis americana. Me1iqethes aeneus , Ceutorynchus sp. , Psylliodes chrysocephala , and Phyllotreta undulata and particularly against the Colorado potato beetle, Leptinotarsa decemlineata, which is a major pest of economically important crops. Also in accordance with this invention, a plant cell genome is transformed with the insecticidally effective btI109P or btI260 gene part, preferably the truncated btI109P or btI260 gene. It is preferred that this transformation be carried out with the btI109P or btI260 chimaeric gene. The resulting transformed plant cell can be used to produce a transformed plant in which the plant cells in some or all of the plant tissues: 1) contain the insecticidally effective btI109P or btI260 gene part as a stable insert in their genome and 2) express the insecticidally effective btI109P or btI260 gene part by producing an insecticidally effective portion of its respective BtI109P or BtI260 protoxin, preferably its respective BtI109P or BtI260 toxin, thereby rendering the plant resistant to Coleoptera. The transformed plant cells of this invention can also be used to produce, for recovery, such insecticidal Bt proteins. Further in accordance with this invention, a process is provided for rendering a plant resistant to Coleoptera by transforming the plant cell genome with the insecticidally effective btI109P or btI260 gene part, preferably the truncated btI109P or btI260 gene. In this regard, it is preferred that the plant cell be transformed with the btI109P or btI260 chimaeric gene. Still further in accordance with this invention, there are provided the BtI109P and BtI260 protoxins, the insecticidally effective portions of such protoxins and the BtI109P and BtI260 toxins, as well as the btI109P and btI260 genes, the insecticidally effective btI109P and btI260 gene parts, the truncated btI109P and btI260 genes and the chimaeric btI109P and btI260 genes. Yet further in accordance with this invention, a Bt strain is transformed, preferably by electroporation, with a vector carrying all or part of the btI109P or btI260 gene encoding all or an insecticidally effective portion of the BtI109P or BtI260 protoxin. Also in accordance with this invention are provided an insecticidal composition against Coleoptera and a method for controlling Coleoptera with the insecticidal composition, wherein the insecticidal composition comprises the BtI260 or BtI109P strain, crystals, crystal proteins, protoxin, toxin and/or insecticidally effective protoxin portions. Detailed Description of the Invention In accordance with this invention, the BtI109P and BtI260 protoxins can be isolated in a conventional manner from, respectively, the BtI109P strain, deposited at the DSM under accession number 5870, and the BtI260 strain, deposited at the DSM under accession number 5871. For example, the BtI109P and BtI260 crystals can be isolated from sporulated cultures of their respective strains (Mahillon and Delcour, 1984), and then, the respective protoxins can be isolated from these crystals according to the method of Hόfte et al (1986). The protoxins can be used to prepare monoclonal or polyclonal antibodies specific for these protoxins in a conventional manner (Hόfte et al, 1988). The BtI109P toxin can then be obtained by protease digestion (e.g., by trypsin digestion) of the BtI109P protoxin. The BtI260 toxin can be obtained by protease digestion (e.g., by trypsin digestion) of the BtI260 protoxin. The btI109P and btI260 genes can also be isolated from their respective strains in a conventional manner. For example, the btI109P or btI260 gene can be identified in its respective BtI109P or BtI260 strain, using the procedure described in U.S. patent application 821,582 and in EPA 86300291.1 and EPA 88402115.5 (which are incorporated herein by reference) . Preferably, the btI109P and btI260 genes are each identified by: digesting total DNA from their respective BtI109P and BtI260 strains with one or more restriction enzymes; size fractionating the DNA fragments, so produced, into DNA fractions of 5 to 10 Kb; ligating such fractions to cloning vectors; transforming E. coli with the cloning vectors; and screening the clones with a suitable DNA probe. The DNA probe can be constructed: 1) from a highly conserved region of a bt gene which encodes another crystal protoxin against Coleoptera such as: the bt!3 gene described in EPA 88402115.5 and by Hόfte et al (1987); or 2) on the basis of the N-terminal amino acid sequence of the protoxin encoded by the respective btI109P or btI260 gene, which sequence can be determined by gas-phase sequencing of the immobilized protoxin (EPA 88402115.5). Alternatively, the 5 to 10 kB fragments, prepared from total DNA of the BtI109P or BtI260 strain, can be ligated in suitable expression vectors and transformed in E. coli. The clones can then be screened by conventional colony immunoprobing methods (French et al, 1986) for expression of the BtI109P or BtI260 toxin with monoclonal or polyclonal antibodies raised against the toxin. The so-identifed btI109P and btI260 genes can then each be sequenced in a conventional manner (Maxam and Gilbert, 1980) to obtain the DNA sequences. Hybridizations in Southern blots indicate that these genes are different from previously described genes encoding protoxins and toxins with activity against Coleoptera (Hόfte and Whiteley, 1989) . An insecticidally effective part of each of the genes, encoding an insecticidally effective portion of its protoxin, and a truncated part of each of the sequenced genes, encoding just its toxin, can be made in a conventional manner from each gene after the gene has been sequenced. The amino acid sequences of the BtI109P and BtI260 protoxins and toxins can further be determined from the DNA sequences of their respective btI109P and btI260 genes and truncated btI109P and btI260 genes. By "an insecticidally effective part" or "a part" of the btI109P or btI260 gene is meant a DNA sequence encoding a polypeptide which has fewer amino acids then the respective BtI109P or BtI260 protoxin but which is still toxic to Coleoptera. Such a part of the btI109P or btI260 gene can encode a BtI109P or BtI260 protoxin which has been truncated towards at least one trypsin cleavage site of the protoxin (U.S. patent application 821,582; EPA 86300291.1). In order to express all or an insecticidally effective part of the btI109P or btI260 gene in E. coli and in plants, suitable restriction sites can be introduced, flanking each gene or gene part. This can be done by site directed mutagenesis, using well-known procedures (Stanssens et al, 1987; Stanssens et al, 1989) . The insecticidally effective btI109P or btI260 gene part, encoding an insecticidally effective portion of its respective BtI109P or BtI260 protoxin, can be stably inserted in a conventional manner into the nuclear genome of a single plant cell, and the so- transformed plant cell be used in a conventional manner to produce a transformed plant that is insect- resistant. In this regard, a disarmed Ti-plasmid, containing the insectidicidally effective btI109P or btI260 gene part, in Aqrobacterium tumefaciens can be used to transform the plant cell, and thereafter, a transformed plant can be regenerated from the transformed plant cell using the procedures described, for example, in EP 116,718 and EP 270,822, PCT publication WO 84/02,913, EPA 87400544.0 and Gould et al. (1991) (which are also incorporated herein by reference) . Preferred Ti-plasmid vectors each contain the insecticidally effective btI109P or btI260 gene part between the border sequences, or at least located to the left of the right border sequence, of the T-DNA of the Ti-plasmid. Of course, other types of vectors can be used to transform the plant cell, using procedures such as direct gene transfer (as described, for example, in EP 233,247), pollen mediated transformation (as described, for example, in EP 270,356, PCT publication WO 85/01856, and US patent 4,684,611), plant RNA virus-mediated transformation (as described, for example, in EP 67,553 and US patent 4,407,956), liposome-mediated transformation (as described, for example, US patent 4,536,475), and other methods such as the recently described methods for transforming certain lines of corn (Fromm et al, 1990; Gordon-Kam et al, 1990). The resulting transformed plant can be used in a conventional plant breeding scheme to produce more transformed plants with the same characteristics or to introduce the insecticidally effective btI109P or btI260 gene part in other varieties of the same or related plant species. Seeds, which are obtained from the transformed plants, contain the insecticidally effective btI109P or btI260 gene part as a stable genomic insert. Cells of the transformed plant can be cultured in a conventional manner to produce the insecticidally effective portion of the respective BtI109P or BtI260 protoxin, preferably the respective BtI109P or BtI260 toxin, which can be recovered for use in conventional insecticide compositions against Coleoptera (U.S. patent application 821,582; EPA 86300291.1.) . The insecticidally effective btI109P or btI260 gene part, preferably the truncated btI109P or btI260 gene, is inserted in a plant cell genome so that the inserted part of the gene is downstream (i.e., 3') of, and under the control of, a promoter which can direct the expression of the gene part in the plant cell. This is preferably accomplished by inserting the btI109P or btI260 chimaeric gene in the plant cell genome. Preferred promoters include: the strong constitutive 35S promoters (the "35S promoters") of the cauliflower mosaic virus of isolates CM 1841 (Gardner et al, 1981) , CabbB-S (Franck et al, 1980) and CabbB-JI (Hull and Howell, 1987); and the TR1' promoter and the TR2' promoter (the "TR1 1 promoter" and "TR2 1 promoter", respectively) which drive the expression of the 1* and 2' genes, respectively, of the T-DNA (Velten et al. 1984) . Alternatively, a promoter can be utilized which is not constitutive but rather is specific for one or more tissues or organs of the plant (e.g., leaves and/or roots) whereby the inserted btI109P or btI260 gene part is expressed only in cells of the specific tissue(s) or organ(s). For example, the btI109P or btI260 gene part could be selectively expressed in the leaves of a plant (e.g., potato, corn, oilseed rape and rice) by placing the gene part under the control of a light-inducible promoter such as the promoter of the ribulose-l,5-bisphosphate carboxylase small subunit gene of the plant itself or of another plant such as pea as disclosed in U.S. patent application 821,582 and EPA 86300291.1. Another alternative is to use a promoter whose expression is inducible (e.g., by temperature or chemical factors) . The insecticidally effective btI109P or btI260 gene part is inserted in the plant genome so that the inserted part of the gene is upstream (i.e., 5') of suitable 3' end transcription regulation signals (i.e., transcript formation and polyadenylation signals) . This is preferably accomplished by inserting the btI109P or btI260 chimaeric gene in the plant cell genome. Preferred polyadenylation and transcript formation signals include those of the octopine synthase gene (Gielen et al, 1984) and the T-DNA gene 7 (Velten and Schell, 1985), which act as 3'-untranslated DNA sequences in transformed plant cells. It is preferred that the insecticidally effective btI109P or btI260 gene part be inserted in the plant genome in the same transcriptional unit as, and under the control of, the same promoter as a selectable marker gene. The resulting hybrid btI109P or btl260- marker gene will, thereby, be expressed in a transformed plant as a fusion protein (U.S. patent application 821,582; EPA 86300291.1; Vaeck et al, 1987) . This result can be preferably accomplished by inserting a btI109P or btI260 chimaeric gene, containing the marker gene, in the plant cell genome. Any conventional marker gene can be utilized, the expression of which can be used to select transformed plant cells. An example of a suitable selectable marker gene is an antibiotic resistance gene such as the neo gene coding for kana ycin resistance (Reiss et al, 1984; EPA 87400544.0; U.S. patent application 821,582; EPA 86300291.1). Thereby, the insecticidally effective btI109P or btI260 gene part and the marker gene (e.g., the btI109P-neo or btI260-neo hybrid gene) are expressed in a transformed plant as a fusion protein (U.S. patent application 821,582; EPA 86300291.1; Vaeck et al, 1987) . All or an insecticidally effective part of the btI109P and btI260 genes, encoding Coleopteran toxins, can also be used to transform gram-positive bacteria, such as a B. thurinqiensis which has insecticidal activity against Lepidoptera or Coleoptera. Thereby, a transformed Bt strain can be produced which is useful for combatting both Lepidopteran and Coleopteran insect pests or combatting additional Coleopteran insect pests. Transformation of a bacteria with all or part of the btI109P or btI260 gene, incorporated in a suitable cloning vehicle, can be carried out in a conventional manner, preferably using conventional electroporation techniques as described in PCT patent application PCT/EP89/01539, filed December 11, 1989. The BtI109P or BtI260 strain also can be transformed with all or an insecticidally effective part of one or more foreign Bt genes such as: the bt2 gene (U.S. patent application 821,582; EPA 86300291.1) or another Bt gene coding for all or an insecticidally effective portion of a Bt protoxin active against Lepidoptera; and/or the bt!3 gene (EPA 88402115.5) or another Bt gene, such as the btPGSI208 gene or btPGSI245 gene (EPA 89400428.2; PCT publication WO 90/09445) , coding for all or an insecticidally effective portion of a Bt protoxin active against Coleoptera. Thereby, a transformed Bt strain can be produced which is useful for combatting an even greater variety of insect pests, e.g., Lepidoptera and/or additional Coleoptera. Transformation of the BtI109P or BtI260 strain with all or part of a foreign Bt gene, incorporated in a conventional cloning vector, can be carried out in a well known manner, preferably using conventional electroporation techniques (Chassy et al, 1988). Each of the BtI109P and BtI260 strains can be fermented by conventional methods (Dulmage, 1981) to provide high yields of cells. Under appropriate conditions which are well understood (Dulmage, 1981) , the BtI109P and BtI260 strains each sporulate to provide their respective BtI109P and BtI260 crystal proteins in high yields. The BtI109P and BtI260 strains, crystals, protoxins, toxins and/or insecticidally effective portions, preferably their protoxins, can each be used as the active ingredient in an insecticide composition used to control insect pests belonging to the order of Coleoptera. For example, the BtI109P or BtI260 crystals can be isolated from sporulated cultures of the BtI109P or BtI260 strain (Mahillon and Delcour, 1984), and then, the respective protoxin can be isolated from these crystals according to the method of Hόfte et al (1986). An insecticidal, particularly anti-Coleopteran, composition of this invention can be formulated in a conventional manner using the BtI109P or BtI260 strain or preferably its respective crystals, crystal proteins, protoxin, toxin and/or insecticidally effective portion of its protoxin as active ingredient(s) , together with suitable carriers, diluents, emulεifiers and/or dispersants. This insecticide composition can be formulated as a wettable powder, pellets, granules or dust or as a liquid formulation with aqueous or non-aqueous solvents as a foam, gel, suspension, concentrate, etc. The concentration of the BtI109P or BtI260 strain, crystals, crystal proteins, protoxin, toxin and/or insecticidally effective protoxin portion in such a composition will depend upon the nature of the formulation and its intended mode of use. Generally, an insecticide composition of this invention can be used to protect a potato field for 2 to 4 weeks against Coleoptera with each application of the composition. For more extended protection (e.g. , for a whole growing season) , additional amounts of the composition should be applied periodically. A method for controlling insects, particularly Coleoptera, in accordance with this invention preferably comprises applying (e.g., spraying), to a locus (area) to be protected, an insecticidal amount of the BtI109P or BtI260 crystals, crystal proteins, protoxin, toxin or insecticidally effective protoxin portion, preferably protoxin. The locus to be protected can include, for example, the habitat of the insect pests or growing vegetation or an area where vegetation is to be grown. To obtain the BtI109P or BtI260 protoxin or toxin, cells of the BtI109P or BtI260 strain can be grown in a conventional manner on a suitable culture medium and then lysed using conventional means such as enzymatic degradation or detergents or the like. The protoxin can then be separated and purified by standard techniques such as chromatography, extraction, electrophoresis, or the like. The toxin can then be obtained by trypsin digestion of the protoxin. The BtI109P or BtI260 cells also can be harvested and then applied intact, either alive or dead, preferably dried, to the locus to be protected. In this regard, it is preferred that a purified BtI109P or BtI260 strain (either alive or dead) be used, particularly a cell mass that is 90.0 to 99.9% BtI109P or BtI260 strain. The BtI109P or BtI260 cells, crystals, crystal proteins, protoxin, toxin, or insecticidally effective protoxin portion can be formulated in an insecticidal composition in a variety of ways, using any number of conventional additives, wet or dry, depending upon the particular use. Additives can include wetting agents, detergents, stabilizers, adhering agents, spreading agents and extenders. Examples of such a composition include pastes, dusting powders, wettable powders, granules, baits and aerosol compositions. Other Bt cells, crystals, crystal proteins, protoxins, toxins, and insecticidally effective protoxin portions and other insecticides, as well as fungicides, biocides, herbicides and fertilizers, can be employed along with the BtI109P or BtI260 cells, crystals, crystal proteins, protoxin, toxin and/or insecticidally effective protoxin portion to provide additional advantages or benefits. Such an insecticidal composition can be prepared in a conventional manner, and the amount of the BtI109P or BtI260 cells, crystals, crystal proteins, protoxin, toxin, and/or insecticidally effective protoxin portion employed depends upon a variety of factors, such as the insect pest targeted, the composition used, the type of area to which the composition is to be applied, and the prevailing weather conditions. Generally, the concentration of the BtI109P or BtI260 protoxin, insecticidally effective protoxin portion and/or toxin will be at least about 0.1% of the weight of the formulation to about 100% by weight of the formulation, more often from about 0.15% to about 0.8% weight percent of the formulation. In practice, some insects can be fed the BtI109P or BtI260 protoxin, toxin, insecticidally effective protoxin portion or mixtures thereof in the protected area, that is, in the area where such protoxin, toxin and/or insecticidally effective protoxin portion have been applied. Alternatively, some insects can be fed intact and alive cells of the BtI109P or BtI260 strain or transformants thereof, so that the insects ingest some of the strain's protoxin and suffer death or damage. The following Examples illustrate the invention. The Figures and Sequence Listing, referred to in the Examples, are as follows : Figures Figure 1 - Total protein patterns by SDS-PAGE of sporulated BtI109P, BtI260, BtSl and BtPGSI208 Bacillus cultures. "MW" designates molecular weight markers. Figure 2 - Hybridisation pattern under low stringency conditions of EcoRI digested total DNA prepared from strains BtSl, BtPGSI208, BtI109P and BtI260 with a 1.46 kb Pstl-EcoRV fragment of the genome of the BtSl strain, containing an internal fragment of the bt!3 gene ("crylllA" gene) as probe. Figure 3 - Hybridisation pattern under low stringency conditions of NlalV digested total DNA prepared from strains BtSl, BtPGSI208, BtI109P and BtI260 with a 1.38 kb EcoRV-NcoI fragment of the genome of the BtPGSI208 strain, containing an internal fragment of the btPGSI208 gene ("crylllB" gene) , as probe. Probe fragments were labeled with 32 P (A) or with digoxygenin (B) (Boehringer Non-Radioactive Labeling Kit). Sequence Listing Seq. Id. No.l - DNA sequence of the btI109P gene. The derived aminoacid sequence of the encoded BtI109P protoxin is presented beneath the DNA sequence. The truncated btI109P gene, coding just for the BtI109P toxin, appears to extend from nucleotide position 397 to the TAA termination codon at nucleotide position 2179. Seq. Id. No.2 - Partial DNA sequence of the btI260 gene. The derived partial aminoacid sequence of the encoded BtI260 protoxin is presented beneath the DNA sequence. Unless otherwise stated in the Examples, all procedures for making and manipulating recombinant DNA are carried out by the standardized procedures described in Maniatis et al. Molecular Cloning - A laboratory Manual, Cold Spring Harbor Laboratory (1982) . Example 1: Characterization of the BtI109P and BtI260 strains. The BtI109P strain was isolated from grain dust sampled in the Philippines and was deposited at the DSM on April 4, 1990 under accession No. 5870. The BtI260 strain was isolated from bat dung sampled in the Philippines and was deposited at the DSM on April 4, 1990 under accession No. 5871. Each strain can be cultivated on conventional standard media, preferably LB medium (Bacto-tryptone 10 g/1, yeast extract 5 g/1, NaCl 10 g/1 and agar 15 g/1) , preferably at 28*C. For long term storage, it is preferred to mix an equal volume of a spore-crystal suspension with an equal volume of 50% glycerol and store this at -70*C or lyophilize a spore suspension. For sporulation, the use of T 3 medium (tryptone 3 g/1, tryptose 2 g/1, yeast extract 1.5 g/1, 5 mg MnCl 2 , 0.05 M Na 2 P0 4 , pH 6.8 and 1.5% agar) is preferred for 24 hours at 28 * C, followed by storage at 4'C. During its vegetative phase, each of the BtI109P and BtI260 strains can also grow under facultative anaerobic conditions, but sporulation only occurs under aerobic conditions. Sterilization of each strain occurs by autoclave treatment at 120*C (1 bar pressure) for 20 minutes. Such treatment totally inactivates the spores and the crystalline BtI109P and BtI260 protoxins. UV radiation (254 nm) inactivates the spores but not the protoxins. After cultivating on Nutrient Agar ("NA", Difco Laboratories, Detroit, MI, USA) for one day, colonies of each of the BtI109P and BtI260 strains form opaque white colonies with irregular edges. Cells of each strain (Gram positive rods of 1.7-2.4 x 5.6-7.7 230m) sporulate after three days cultivation at 28'C on NA. The crystal proteins produced during sporulation are packed in flat square crystals in the BtI109P strain and in small rhomboid crystals in the BtI260 strain. Both strains were further characterized by εerotyping with B. thurinqiensis H antisera (by H. de Barjac of Institut Pasteur, France) . BtI109P belongs to serotype H 303b, at an agglutination titre of 25,000 with Bt kurstaki. BtI260 belongs to serotype H18, at an agglutination titre of 3,200 with Bt kumamotoensis. Example 2: Characteristics of the BtI109P and BtI260 crystals The BtI109P and BtI260 strains were grown for 48 to 72 hours at 28*C on T 3 medium. After sporulation, the spores and crystals were harvested in phosphate buffered saline solution ("PBS" from Oxoid Ltd., Basingstroke, Hampshire, U.K.). The resulting aqueous spore-crystal suspensions were centrifuged, and the pellets were resuspended in PBS, recentrifuged and the pellet resuspended again. The total protein patterns of the sporulated cultures of BtI109P and BtI260 strains were compared (Fig.l) to other Bacillus strains, which produce the CrylllA or CrylllB crystal proteins, according to Lambert et al (1987) . For this comparison, an aliquot of the washed spore-crystal mixture of each strain was centrifuged, the supernatant discarded and the pellet solubilized in Sample Buffer Mix. The extracts containing crystal proteins, were analyzed on a 12.5% SDS-PAGE gel (Laemmli, 1970) and stained with Coomassie brilliant blue R-250. The results of this analysis revealed the presence of a major band (molecular weight 65.5 kDa) and two minor bands (MW. 72.4 kDa and 49.1 kDa) in spore-crystals of strain BtI109P and two major bands of about 65 kDa and a band of about 30 kDa in spore-crystals of strain BtI260. Furthermore, the overall protein patterns of BtI109P and BtI260 are clearly different from the overall protein pattern of BtSl. Example 3: Insecticidal activity of the BtI109P and BtI260 crystal proteins As in Example 2, both strains were grown for 48 to 72 hrs at 28*C on T 3 medium. After sporulation, the spores and crystals were harvested in PBS (phosphate buffered saline) . The resulting spore-crystal suspensions were centrifuged, and the pellets were resuspended, recentrifuged and the pellets again resuspended after removal of the supernatant. The pellets were incubated overnight in aqueous solutions containing 50 mM Na 2 CC> 3 and 5 mM dithiotreitol. After centrifugation, the supernatants were recovered, and the protein contents of the extracts of the respective crystal proteins of the two strains were determined. Potato leaves were dipped either in standardized spore-crystal mixtures or in aqueous dilutions of the crystal protein solutions and then air dried for two hours. Colorado potato beetle larvae of the first instar were placed on the treated leaves, and mortality of the larvae was determined after three days. These results were compared with the mortality of larvae fed leaves treated with either spore-crystal mixtures or solubilized crystal proteins of BtSl (from DSM, accession no. 4288) which was used as a reference strain. LC50 (50% lethal concentration) , expressed either as ug of solubilized crystal proteins/ml solution or as the number of spore-crystals in the dip-suspension, was calculated by Probit analysis (Finney, 1971). The results, including the 95% confidence interval and the slope of the probit line, are summarized in Tables 1 and 2, below. Table I: Comparison of the toxicity of solubilized crystal proteins from the BtI109P strain, the Btl260 strain, the Bt San Diego strain (NRRL accession no. B-15939) and the BtSl strain (reference strain) against larvae of Leptinotarsa decemlineata. Table 2: Comparison of the toxicity of spore-crystal mixtures from the BtI109P strain, the BtI260 strain and the BtSl strain (reference strain) against larvae of Leptinotarsa decemlineata. Example 4: Identification of the btI109P and btI260 genes The BtI109P and BtI260 protoxins from the BtI109P and BtI260 strains respectively were detected by ELISA (Engvall and Pesce, 1978) with a polyclonal antiserum against the Btl3 coleopteran toxin (Hόfte et al, 1987). The btI109P and btI260 genes were identified in their respective strains by preparing total DNA of these strains and then digesting the DNA with the restriction enzymes NlalV and EcoRI. The EcoRI-digested DNA was analyzed by Southern blotting, probing with a K P labeled 1.46 kb Pstl-EcoRV fragment from the genome of the BtSl strain (EPA 88402115.5) containing the bt!3 gene. After hybridization with the probe, the blot was washed under low stringency conditions (2XSSC, 0.1%SDS at 68*C for 2x15 min) and developed. The autoradiogram (Fig. 2) shows that only the btI109P gene is related to the bt!3 gene. The hybridization pattern with the probe also showed that the btI109P gene was clearly different from the bt!3 gene and that the genome of the BtI260 strain did not contain DNA sequences that are related to the Pstl-EcoRV probe fragment of bt!3 (crylllA) under the experimental conditions used. (Fig. 2) The NlalV-digested DNA was analyzed by Southern blotting, probing with ^P-labeled or digoxygenin (Non-Radioactive Labeling Kit, Boehringer Mannheim, Mannheim, Germany) 1.38 kb EcoRV-Ncol fragment from the genome of the BtPGSI208 strain (PCT patent application PCT/EP90/00244) containing the btPGSI208 or crylllB gene. After hybridization with the probe, the blot was washed under low stringency conditions (2XSSC, 0.1%SDS at 68*C for 2x15 min) and developed. The results (Fig. 3) show that only the btI260 gene is related to the btPGSI208 gene. The hybridization pattern with the probe also showed that the btI260 gene was clearly different from the btPGSI208 gene and that the btI109P gene strain contains DNA sequences that are only distantly related to the btPGSI208 gene under the experimental conditions used (Fig. 3) . Example 5: Cloning and expression of the btI109P gene In order to isolate the btI109P gene, total DNA from the BtI109P strain was prepared. Subsequently, total DNA was digested with Hindlll. The digested DNA was size fractionated on a sucrose gradient, and fragments ranging from 5 kb to 7 kb were ligated to the Hindlll-digested and BAP-treated cloning vector pUC19 (Yanisch-Perron et al, 1985) . Recombinant E.coli clones, "pUC.crylllDHdl", containing the vector were then screened with an internal 1.4 kb EcoRV-PstI DNA fragment of the bt!3 gene (EP 305,275), as a probe, to identify clones containing the btI109P gene. The so-identified DNA fragments were then sequenced (Seq. Id. No. 1) according to Maxam and Gilbert (1980). Based on the analysis of its DNA sequence, the gene is cut with appropriate restriction enzymes to give the truncated btI109P gene, encoding the BtI109P toxin. Example 6: Cloning and expression of the btI260 gene In order to isolate the btI260 gene, total DNA from the BtI260 strain is prepared and partially digested with Sau 3A. The digested DNA is size fractioned on a sucrose gradient and fragments ranging from 5Kb to 10 Kb are ligated to the Bglll - digested and BAP-treated cloning vector pECOR251 (deposited under accession no. 4711 at DSM) . Recombinant E.coli clones are then screened with an internal NcoI-EcoRV DNA fragment of the btPGSI208 gene (EP 382,990), as a probe, to identify clones containing the btI260 gene. DNA fragments containing the btI260 gene are then sequenced (Seq. Id. no. 2) according to Maxam and Gilbert (1980). Based on the analysis of its DNA sequence, the gene is cut with appropriate restriction enzymes to give the truncated btI260 gene encoding the BtI260 toxin. Example 7: Construction of a btI109P-neo hybrid gene and a btI260-neo hybrid gene Following the procedure of U.S. patent application 821,582 and EPA 88402115.5 and EPA 86300291.1, the truncated btI109P and btI260 genes from Examples 5 and 6 are each fused to the neo gene to form the corresponding hybrid gene. Example 8: Insertion of the btI109P and btI260 genes, the truncated btI109P and btI260 genes and the btI109P-neo and btI260-neo hybrid genes in E. coli and insertion of the truncated btI109P and btI260 genes and the btI109P-neo and btI260-neo hybrid genes in potato plants In order to express the btI109P gene and btI260 gene, the truncated btI109P gene and truncated btI260 gene, and the btI109P-neo hybrid gene and btI260-neo hybrid gene from Examples 5, 6 and 7 in E. coli and in plants, different gene cassettes are made in E. coli according to the procedures described in EPA 86300291.1 and EPA 88402115.5. To allow major expression in plants, cassettes, each containing one of the truncated and/or hybrid genes, are each inserted in an intermediate plant expression vector (between the T-DNA border sequences of this vector) , are each fused to transcript formation and polyadenylation signals in the plant expression vector, are each placed under the control of a constitutive promoter such as the promoter from cauliflower mosaic virus driving the 35S3 transcript (Hull and Howell, 1987) or the 2' promoter from the TR-DNA of the octopine Ti-plasmid (Velten et al, 1984), and are each fused to 3• end transcript formation and polyadenylation signals capable of acting in plants, such as the 3* end of the octopine synthase gene (Gielen et al, 1984) . Using standard procedures (Deblaere et al, 1985), the intermediate plant expression vectors, containing the truncated btI109P and btI260 genes and the btI109P-neo and btI260-neo hybrid genes, are transferred into the Agrobacterium strain C 58 Cl Rif R (US patent application 821,582; EPA 86300291.1) carrying the disarmed Ti-plasmid pGV2260 (Vaeck et al, 1987) . Selection for spectinomycin resistance yields cointegrated plasmids, consisting of pGV2260 and the respective intermediate plant expression vectors. Each of these recombinant Agrobacterium strains is then used to transform different potato plants (Solanum tuberosum) so that the truncated btI109P gene, the truncated btI260 gene, the btI109P-neo hybrid gene and the btI260-neo hybrid gene are contained in, and expressed by, different potato plant cells. Example 9: Expression of the truncated btI109P and btI260 genes and the btI109P-neo and btI260-neo hybrid genes in potato plants The insecticidal activity against Coleoptera of the expression products of the truncated btI109P and btI260 genes and the btI109P-neo and btI260-neo hybrid genes in leaves of transformed potato plants, generated from the transformed potato plant cells of Example 8, is evaluated by recording the growth rate and mortality of Leptinotarsa decemlineata larvae fed on these leaves. These results are compared with the growth rate of larvae fed leaves from untransformed potato plants. Toxicity assays are performed as described in EPA 88402115.5, U.S. patent application 821,582 and EPA 86300291.1. A significantly higher mortality rate is obtained among larvae fed on leaves of transformed potato plants containing the truncated btI109P gene, the truncated btI260 gene, the btI109P-neo hybrid gene or the btI260-neo hybrid gene than among larvae fed the leaves of untransformed plants. Needless to say, this invention is not limited to the BtI109P (DSM 5870) strain and the BtI260 (DSM 5871) strain. Rather, the invention also includes any mutant or variant of the BtI109P or BtI260 strain which produces crystals, crystal proteins, protoxin or toxin having substantially the same properties, particularly insecticidal properties, as the BtI109P or BtI260 crystals, crystal proteins, protoxin or toxin. In this regard, variants of the BtI109P and BtI260 strains include variants whose total protein pattern is substantially the same as the protein pattern of either the BtI109P strain or the BtI260 strain as shown in Fig. 1. This invention also is not limited to potato plants transformed with the truncated btI109P or btI260 gene. It includes any monocotyledonous or dicotyledonous plant, such as tomato, tobacco, rapeseed, alfalfa, sunflowers, cotton, corn, soybeans, brassicas, sugar beets and other vegetables, transformed with an insecticidally effective btI109P or btI260 gene part. Nor is this invention limited to the use of Agrobacterium tumefaciens Ti-plasmids for transforming plant cells with an insecticidally effective btI109P or btI260 gene part. Other known techniques for plant cell transformations, such as by means of liposomes, by electroporation or by vector systems based on plant viruses or pollen, can be used for transforming monocotyledons and dicotyledons with such a gene part. For example, an insecticidally effective btI109P or btI260 gene part can be used to transform certain selected lines of corn and rice plants by methods such as are described by From et al (1990), Gordon-Kamm et al (1990), Shimamoto et al (1989) and Datta et al (1990) . Furthermore, DNA sequences other than those present naturally in the BtI109P and BtI260 strains and encoding respectively the natural BtI109P and BtI260 protoxins, toxins and insecticidally effective protoxin portions can be used for transforming plants and bacteria. In this regard, the natural DNA sequence of these genes can be modified by: 1) replacing some codons with others that code either for the same amino acids or for other, preferably equivalent, amino acids; and/or 2) deleting or adding some codons; provided that such modifications do not substantially alter the properties, particularly the insecticidal properties, of the encoded BtI109P or BtII260 protoxin, the insecticidally effective portion of the BtIl09P or BtI260 protoxin or the BtI109P or BtI260 toxin. Also, other DNA recombinants containing the aforementioned DNA sequences in association with other foreign DNA, particularly the DNA of vectors suitable for transforming plants and microorganisms other than •__• coli, are encompassed by this invention. In this regard, this invention is not limited to the specific plasmids containing the btI109P and btI260 genes, or parts thereof, that were heretofore described, but rather, this invention encompasses any DNA recombinants containing a DNA sequence that is their equivalent. Further, the invention relates to all DNA recombinants that include all or part of either the btI109P gene or the btI260 gene and that are suitable for transforming microorganisms (e.g., plant-associated bacteria such as Bacillus subtilis, Pseudomonas , and Xanthomonas or yeasts such as Strepto yces cerevisiae) under conditions which enable all or part of the gene to be expressed and to be recoverable from said microorganisms or to be transferred to a plant cell. References Chassy et al., Trends in Biotechnology (5,303-309 (1988) Datta S., Peterhans A., Datta K. and Potrykus I., Bio/Technology S , 736-740 (1990) . Deblaere, R. , Bijtebier, B. De Greve , H. , Debock, F., Schell, J., Van Montagu, M. and Leemans, J., Nucleic Acids Research 13, 4777-4788 (1985) . Deblaere, R. , Reynaerts A., Hόfte H. , Hernalsteens J.-P., Leemans J. and Van Montagu M., Methods in Enzy ology 153, 277-292 (1988). Dulmage, H.T., "Production of Bacteria for Biological Control of Insects" in Biological Control in Crop Production, Ed. Paparizas, D.C., Osmun Publishers, Totowa, N.J., USA, pp. 129-141 (1981) . Ellar, D.J., Knowles, B.H., Drobniewski, S.A. and Haider, M.Z., in "Fundamental and Applied aspects of Invertebrate Pathology". Ed. Samson, R.A., Vlak, J.M. and Peters, D. (1986) pp. 7-10. Wageningen, Foundation of the fourth International Colloqium of Invertebrate Pathology. Engvall and Pesce, Scand. Immunol. Suppl. 7 (1978) Finney, Probit Analysis, 3rd Edition, Cambridge University Press (1971) Franck, Guilley, Jonard, Richards and Hirth, Cell 21, 285-294 (1980) French, B.T., Maul, H N. and Maul, G.G., Anal.Biochem. 1!56, 417423 (1986) Fromm M., Morrish F., Armstrong C, Williams R. , Thomas J. and Klein T. , Bio/Technology 1$, 833-839 (1990) . Gardner, Howarth, Hahn, Brown-Luedi, Shepard and Messing, Nucleic Acids Research 9, 2871-2887 (1981) Gielen, J., De Beukeleer, M. , Seurinck, J., Deboeck, F., De Greve, H. , Lemmers, M., Van Montagu, M. and Schell, J., EMBO J 3_, 835-845 (1984). Gordon-Kamm W., Spencer M., Mangano M., Adams T., Daines R., Start W., O'Brien J., Chambers S., Adams W., Willets N. , Rice T. , Mackey C, Krueger R. , Kausch A. and Lemaux P. , The Plant Cell 2 , 603-618 (1990) . Gould et al., Plant Physiology 9J5, 426-434 (1991). Hόfte, H., De Greve, H., Seurinck, J., Jansens, S., Mahillon, J. , Ampe, Vandekerckhove, J, Vanderbruggen, H., Van Montagu, M., Zabeau, M. and Vaeck, M., Eur. J. Biochem. 161, 273-280 (1986) Hόfte, H., Seurinck, J., Van Houtven A. and Vaeck, M. , Nucleic Acids Research 15, 7183 (1987) Hόfte, H. , Dissertation thesis at the State University of Ghent, Belgium (1988) . Hόfte, H., Van Rie, J., Jansens, S., Van Houtven, A., Verbruggen, H. and Vaeck, M., Applied and Environmental Microbiology 54, 2010-2017 (1988) Hόfte H. and Whiteley H.R. , Microbiological Review 53.,_242-255 (1989) . Hull and Howell, Virology 8 , 482-493 (1987) Laemmli V., Nature 22 , 680-685 (1970) Lambert, B., Leyns, F. , Van Rooyen, L. , Gossele, F., Papon, Y. and Swings, J. Applied and Environmental Microbiology 5 , 1866-1871 (1987) Mahillon, J. and Delcour, J., J. Microbiol. Methods 3 , 69-73 (1984) Maxam, A.M. and Gilbert, W. , Methods in Enzymol. 65, 499-560 (1980). Odell , J. T. , Nagy, J . , and Chua, N. , Nature 313 , 810-812 (1985) . Reiss, B. , Sprengel, R., Will, H. and Schaller, H., Gene 3_0, 217-223 (1984). Shimamoto K., Terada R. , Izawa T. and Fujimoto H. , Nature 338, 274-276 (1989). Stanssens P., McKeown Y., Friedrich K. and Fritz H.J. (1988) , "Oligonucleotide-directed construction of mutations by the gapped duplex DNA method using the pMA/c plasmid vectors", published in the collection of additional experimental procedures distributed at the EMBO laboratory course on "Directed mutagenesis and protein engineering" in July 1987 at the Max Planck Institute fur Biochemie, Martinsried, Federal Republic of Germany. Stanssens P., Opsomer C. , McKeown Y., Kramer W. , Zabeau M. and Fritz H.J., Nucleic Acids Research 12, 4441-4454 (1989). Vaeck, M. , Reynaerts, A., Hόfte, H., Jansens, S., De Beuckeleer, M. , Dean, C., Zabeau, M. , Van Montagu, M. and Leemans, J., Nature 327, 33-37(1987) . Velten, J., Velten, L., Hain, R. and Schell, J., EMBO J 3., 2723-2730 (1984). Velten, J. and Schell, J. Nucleic Acids Research 13, 6981-6998 (1985) Yanisch-Perron, C. , Vierra, J. and Messing, J., Gene 33, 103-119 (1985). SEQUENCE LISTING 1. General Information i) APPLICANT : PLANT GENETIC SYSTEM N.V. ii) TITLE OF INVENTION : New Bacillus Thuringiensis Strains and Their Genes Encoding Insecticidal Toxins iii) NUMBER OF SEQUENCES : 2 iv) CORRESPONDENCE ADDRESS : A. ADDRESSEE : Plant Genetic Systems N.V. B. STREET : Plateaustraat 22, C. POSTAL CODE AND CITY : 9000 Ghent, D. COUNTRY : Belgium V) COMPUTER READABLE FORM : A. MEDIUM TYPE 5.25 inch, double sided, high density 1.2 Mb floppy disk B. COMPUTER : IBM PC/AT C. OPERATING SYSTEM : DOS version 3.3 D. SOFTWARE : WordPerfect vi) CURRENT APPLICATION DATA : Not Available (vii) PRIOR APPLICATION DATA : EPA 90403724.9 EPA 90401144.2 SEQ. ID. NO: 1 SEQUENCE TYPE: nucleic acid and corresponding protein SEQUENCE LENGTH: 2411 basepairs STRANDEDNESS: double stranded TOPOLOGY: linear MOLECULAR TYPE: DNA derived from Bacillus thurinqiensis HYPOTHETICAL: NO ANTI-SENSE: NO ORIGINAL SOURCE: A. ORGANISM: Bacillus thuringiensis var. kurstaki B. STRAIN: BtI109P (DSM accession number 5870) INTERNATIONAL SOURCE: pUC.crylllDHdl FEATURES: nucleotides 1-232: 5' (upstream) sequences o the btI109P gene (S) 231-2179: coding sequence of the btI109P gene (S) nucleotides 2180-end: 3 ' (downstream) sequences of the btI109P gene (S) PROPERTIES : the btI109P gene codes for a 72 kD insecticidal crystal protein toxic to Coleoptera CCTGTATATA ATATGCCAAT ACATTGTTAC AATTAATATT TAATCTAATG 50 AAATGTTAAT TATATATATA AATATATCTA TGATAAGTGC ATGAATAATT 100 AAGTTTGAAA GGGGGGATGT GTTAAAAGAA AGAATATTAA AATCTTGTGT 150 TTGTACCGTC TAATGGATTT ATGGGAAATT ATTTTATCAG ATTGAAAGTT 200 ATGTATTATG ACAAGAAAGG GAGGAAGAAA A ATG AAT CCG AAC 243 MET Asn Pro Asn 1 AAT CGA AGT GAA CAT GAT ACA ATA AAA GCT ACT GAA AAT 282 Asn Arg Ser Glu His Asp Thr lie Lys Ala Thr Glu Asn 5 10 15 AAT GAG GTA TCA AAT AAC CAT GCT CAA TAT CCT TTA GCA 321 Asn Glu Val Ser Asn Asn His Ala Gin Tyr Pro Leu Ala 20 25 30 GAT ACT CCA ACA CTG GAA GAA TTA AAT TAT AAA GAG TTT 360 Asp Thr Pro Thr Leu Glu Glu Leu Asn Tyr Lys Glu Phe 35 40 TTA AGA AGG ACT ACA GAT AAT AAT GTG GAA GCA CTA GAC 399 Leu Arg Arg Thr Thr Asp Asn Asn Val Glu Ala Leu Asp 45 50 55 AGC TCA ACA ACA AAA GAT GCC ATT CAA AAA GGG ATT TCC 438 Ser Ser Thr Thr Lys Asp Ala lie Gin Lys Gly lie Ser 60 65 ATA ATA GGT GAT CTC CTA GGT GTA GTA GGT TTC CCA TAT 477 lie lie Gly Asp Leu Leu Gly Val Val Gly Phe Pro Tyr 70 75 80 GGT GGA GCG CTT GTT TCT TTT TAT ACA AAC TTA TTA AAC 516 Gly Gly Ala Leu Val Ser Phe Tyr Thr Asn Leu Leu Asn 85 90 95 ACT ATC TGG CCA GGT GAA GAC CCT TTA AAG GCT TTT ATG 555 Thr He Trp Pro Gly Glu Asp Pro Leu Lya Ala Phe MET 100 105 CAA CAA GTA GAA GCA TTG ATA GAC CAG AAA ATA GCG GAT 594 Gin Gin Val Glu Ala Leu He Asp Gin Lys He Ala Asp 110 115 120 TAT GCG AAA GAT AAA GCA ACT GCA GAG TTA CAA GGA CTT 633 Tyr Ala Lys Asp Lys Ala Thr Ala Glu Leu Gin Gly Leu 125 130 AAA AAT GTT TTC AAA GAT TAT GTT AGT GCA TTG GAT TCA 672 Lys Asn Val Phe Lys Asp Tyr Val Ser Ala Leu Asp Ser 135 140 145 TGG GAC AAA ACT CCT TTG ACT TTA CGA GAT GGA CGA AGC 711 Trp Asp Lys Thr Pro Leu Thr Leu Arg Asp Gly Arg Ser 150 155 160 CAA GGG CGC ATA AGA GAG CTA TTT TCT CAA GCA GAA AGT 750 Gin Gly Arg He Arg Glu Leu Phe Ser Gin Ala Glu Ser 165 170 CAT TTT CGT CGT TCA ATG CCG TCG TTT GCA GTC TCT GGA 789 His Phe Arg Arg Ser MET Pro Ser Phe Ala Val Ser Gly 175 180 185 TAC GAA GTT CTA TTT CTG CCA ACA TAT GCA CAG GCC GCG 828 Tyr Glu Val Leu Phe Leu Pro Thr Tyr Ala Gin Ala Ala 190 195 AAC ACA CAT TTA TTA CTA TTA AAA GAC GCT CAA ATT TAT 867 Asn Th His Leu Leu Leu Leu Lys Asp Ala Gin He Tyr 200 205 210 GGA ACG GAT TGG GGA TAT TCT ACA GAT GAT CTT AAT GAG 906 Gly Thr Asp Trp Gly Tyr Ser Thr Asp Asp Leu Asn Glu 215 220 225 TTT CAC ACA AAA CAA AAG GAT CTT ACG ATA GAA TAT ACA 945 Phe His Thr Lys Gin Lys Asp Leu Thr He Glu Tyr Thr 230 235 AAT CAT TGT GCC AAA TGG TAT AAG GCA GGA TTA GAT AAA 984 Asn His Cys Ala Lys Trp Tyr Lys Ala Gly Leu Asp Lys 240 245 250 TTA AGA GGT TCG ACT TAT GAA GAG TGG GTA AAA TTT AAT 1023 Leu Arg Gly Ser Thr Tyr Glu Glu Trp Val Lys Phe Asn 255 260 CGT TAT CGC AGA GAG ATG ACA TTA ACA GTA TTA GAT TTA 1062 Arg Tyr Arg Arg Glu MET Thr Leu Thr Val Leu Asp Leu 265 270 275 ATT ACG CTG TTT CCA TTG TAT GAT GTT CGA ACA TAC ACT 1101 He Thr Leu Phe Pro Leu Tyr Asp Val Arg Thr Tyr Thr 280 285 290 AAA GGA GTT AAA ACT GAA TTA ACA AGA GAC GTT TTA ACT 1140 Lys Gly Val Lys Thr Glu Leu Thr Arg Asp Val Leu Tlir 295 300 GAT CCA ATT GTT GCC GTC AAC AAT ATG AAT GGC TAT GGA 1179 Asp Pro He Val Ala Val Asn Asn MET Asn Gly Tyr Gly 305 310 315 ACA ACC TTC TCT AAT ATA GAA AAT TAT ATC CGA AAA CCG 1218 Thr Thr Phe Ser Asn He Glu Asn Tyr He Arg Lys Pro 320 325 CAT CTA TTT GAC TAT TTG CAT GCG ATT CAA TTT CAC TCG 1257 His Leu Phe Asp Tyr Leu His Ala He Gin Phe His Ser 330 335 340 CGC TTA CAA CCT GGA TAT TTT GGA ACG GAC TCT TTC AAT 1296 Arg Leu Gin Pro Gly Tyr Phe Gly Thr Asp Ser Phe Asn 345 350 355 TAT TGG AGT GGT AAT TAT GTT TCA ACT AGA TCT AGC ATA 1335 Tyr Trp Ser Gly Asn Tyr Val Ser Thr Arg Ser Ser He 360 365 GGA TCA GAT GAA ATA ATC CGA TCT CCA TTC TAT GGA AAT 1374 Gly Ser Asp Glu He He Arg Ser Pro Phe Tyr Gly Asn 370 375 380 AAA TCT ACT TTA GAT GTT CAA AAT TTA GAA TTT λλC GGG 1413 Lys Ser Thr Leu Asp Val Gin Asn Leu Glu Phe Asn Gly 385 390 GAA AAA GTC TTT AGA GCT GTA GCA AAT GGT AAT CTG GCA 1452 Glu Lys Val Phe Arg Ala Val Ala Asn Gly Asn Leu Ala 395 400 405 GTC TGG CCG GTG GGT ACA GGA GGT ACC AAA ATA CAT TCT 1491 Val Trp Pro Val Gly Thr Gly Gly Thr Lys He His Ser 410 415 420 GGT GTT ACA AAA GTA CAA TTC AGT CAG TAC AAT GAT CGA 1530 Gly Val Thr Lys Val Gin Phe Ser Gin Tyr Asn Asp Arg 425 430 AAA GAT GAA GTA AGA ACA CAA ACG TAT GAC TCA AAA AGA 1569 Lys Asp Glu Val Arg Thr Gin Thr Tyr Asp Ser Lys Arg 435 440 445 AAT GTT GGT GGT ATC GTC TTT GAT TCC ATT GAT CAA TTG 1608 Asn Val Gly Gly He Val Phe Asp Ser He Asp Gin Leu 450 455 CCT CCA ATA ACA ACA GAT GAA TCT CTA GAA AAA GCA TAT 1647 Pro Pro He Thr Thr Asp Glu Ser Leu Glu Lys Ala Tyr 460 465 470 AGT CAT CAA CTC AAT TAC GTA AGG TGC TTC TTA TTG CAG 1686 Ser His Gin Leu Asn Tyr Val Arg Cys Phe Leu Leu Gin 475 480 485 GGT GGA AGA GGA ATA ATC CCA GTG TTT ACT TGG ACA CAT 1725 Gly Gly Arg Gly He He Pro Val Phe Thr Trp Thr His 490 495 AAG AGT GTA GAC TTT TAT AAT ACG CTT GAT TCA GAA AAA 1764 Lys Ser Val Asp Phe Tyr Asn Thr Leu Asp Ser Glu Lys 500 505 510 ATT ACG CAA ATC CCT TTC GTA AAG GCA TTT ATT TTA GTA 1803 He Thr Gin He Pro Phe Val Lys Ala Phe He Leu Val 515 520 AAT AGT ACT TCC GTT GTC GCA GGT CCT GGA TTC ACA GGC 1842 Asn Ser Thr Ser Val Val Ala Gly Pro Gly Phe Thr Gly 525 530 535 GGA GAC ATA ATA AAA TGT ACG AAT GGA TCT GGA TTA ACT 1881 Gly Asp He He Lys Cys Thr Asn Gly Ser Gly Leu Thr 540 545 550 TTA TAT GTT ACA CCG GCA CCG GAC TTG ACG TAT TCT AAA 1920 Leu Tyr Val Thr Pro Ala Pro Asp Leu Thr Tyr Ser Lys 555 560 ACA TAT AAA ATT CGA ATT CGT TAT GCT TCT ACA TCT CAG 1959 Thr Tyr Lys He Arg He Arg Tyr Ala Ser Thr Ser Gin 565 570 575 GTG AGA TTT GGA ATT GAC TTA GGC AGT TAC ACT CAT AGT 1998 Val Arg Phe Gly He Asp Leu Gly Ser Tyr Thr His Ser 580 585 ATT TCG TAT TTC GAT AAA ACG ATG GAT AAA GGA AAT ACA 2037 He Ser Tyr Phe Asp Lys Thr MET Asp Lys Gly Asn Thr 590 595 600 TTA ACG TAT AAT TCA TTT AAT TTA TCA AGT GTC AGC AGA 2076 Leu Thr Tyr Asn Ser Phe Asn Leu Ser Ser Val Ser Arg 605 610 615 CCA ATT GAA ATA TCA GGA GGG AAT AAA ATC GGG GTA TCC 2115 Pro He Glu He Ser Gly Gly Asn Lys He Gly Val Ser 620 625 GTC GGA GGT ATT GGC TCT GGG GAT GAA GTT TAT ATA GAC 2154 Val Gly Gly He Gly Ser Gly Asp Glu Val Tyr He Asp 630 635 640 AAA ATC GAA TTT ATT CCA ATG GAT TAA ATT TTA CTA AAGAGC 2196 Lys He Glu Phe He Pro MET Asp . He Leu Leu 645 650 TAGTATTAAC CACTTAGGAT AATAAGAATC GGGTACAAAA GTAAGTTTAT 2246 AAAATGAATA AAACAGTGTT CTTCATCCTT OSCTTTTTGA AGGTAGACAA 2296 AGAACACTGT TTTTACTTTT AGAATAAATA TTTTTTGTGT AATCACATAA 23 6 AGGGAGCAAA GAAAGTAGGG ATATGTCACT AGCAATTAGA ATTAGTAGAT 2396 CCAGTAAGTA ATTAA 2411 SEQ. ID. NO: 2 SEQUENCE TYPE: nucleic acid and corresponding protein SEQUENCE LENGTH: 1291 basepairs STRANDEDNESS: double stranded TOPOLOGY: linear MOLECULAR TYPE: DNA derived from Bacillus thuringiensis HYPOTHETICAL: NO ANTI-SENSE: NO ORIGINAL SOURCE: A. ORGANISM: Bacillus thuringiensis var. kumamotoensis B. STRAIN: BtI260 (DSM accession number 5871) FEATURES: nucleotides 2-1045: 5' end of the btI260 gene coding for the C-teπninal end of the BTI260 insecticidal protein (numbering of amino acids is incomplete) PROPERTIES: the btI260 gene codes for a 66 kD insecticidal protein toxic to Coleoptera. G AAA GAT CCA ATT TTT TCA CTT AAT ACT CTT CAG GAG 37 Lys Asp Pro He Phe Ser Leu Asn Thr Leu Gin Glu 1 5 10 TAT GGA CCA ACT TTT TTG AGT ATA GAA AAC TCT ATT CGA 76 Tyr Gly Pro Thr Phe Leu Ser He Glu Asn Ser He Arg 15 20 25 AAA CCT CAT TTA TTT GAT TAT TTA CAG GGG ATT GAA TTT 115 Lys Pro His Leu Phe Asp Tyr Leu Gin Gly He Glu Phe 30 35 CAT ACG CGT CTT CAA CCT GGT TAC TTT GGG AAA GAT TCT 154 His Thr Arg Leu Gin Pro Gly Tyr Phe Gly Lys Asp Ser 40 45 50 TTC AAT TAT TGG TCT GGT AAT TAT GTA GAA ACT AGA CCT 193 Phe Asn Tyr Trp Ser Gly Asn Tyr Val Glu Thr Arg Pro 55 60 AGT ATA GGA TCT AGT AAG ACA ATT ACT TCC CCA TTT TAT 232 Ser He Gly Ser Ser Lys Thr He Thr Ser Pro Phe Tyr 65 70 75 GGA GAT AAA TCT ACT GAA CCT GTA CAA AAG CTA AGC TTT 271 Gly Asp Lys Ser Thr Glu Pro Val Gin Lys Leu Ser Phe 80 85 90 GAT GGA CAA AAA GTT TAT CGA ACT ATA GCT AAT ACA GAC 310 Asp Gly Gin Lys Val Tyr Arg Thr He Ala Asn Thr Asp 95 100 GTA GCG GCT TGG CCG AAT GGT AAG GTA TAT TTA GGT GTT 349 Val Ala Ala Trp Pro Asn Gly Lys Val Tyr Leu Gly Val 105 HO 115 ACG AAA GTT GAT TTT AGT CAA TAT GAT GAT CAA AAA AAT 388 Thr Lys Val Asp Phe Ser Gin Tyr Asp Asp Gin Lys Asn 120 125 GAA ACT AGT ACA CAA ACA TAT GAT TCA AAA AGA AAC AAT 427 Glu Thr Ser Thr Gin Thr Tyr Asp Ser Lys Arg Asn Asn 130 135 140 GGC CAT GTA AGT GCA CAG GAT TCT ATT GAC CAA TTA CCG 466 Gly His Val Ser Ala Gin Asp Ser He Asp Gin Leu Pro 145 150 155 CCA GAA ACA ACA GAT GAA CCA CTT GAA AAA GCA TAT AGT 505 Pro Glu Thr Thr Asp Glu Pro Leu Glu Lys Ala Tyr Ser 160 165 CAT CAG CTT AAT TAC GCG GAA TGT TTC TTA ATG CAG GAC 544 His Gin Leu Asn Tyr Ala Glu Cys Phe Leu MET Gin Asp 170 175 180 CGT CGT GGA ACA ATT CCA TTT TTT ACT TGG ACA CAT AGA 583 Arg Arg Gly Thr He Pro Phe Phe Thr Trp Thr His Arg 185 190 AGT GTA GAC TTT TTT AAT ACA ATT GAT GCT GAA AAG ATT 622 Ser Val Asp Phe Phe Asn Thr He Asp Ala Glu Lys He 195 200 205 ACT CAA CTT CCA GTA GTG AAA GCA TAT GCC TTG TCT TCA 661 Thr Gin Leu Pro Val Val Lys Ala Tyr Ala Leu Ser Ser 210 215 220 GGT GCT TCC ATT ATT GAA GGT CCA GGA TTC ACA GGA GGA 700 Gly Ala Ser He He Glu Gly Pro Gly Phe Thr Gly Gly 225 230 AAT TTA CTA TTC CTA AAA GAA TCT AGT AAT TCA ATT GCT 739 Asn Leu Leu Phe Leu Lys Glu Ser Ser Asn Ser He Ala 235 240 245 AAA TTT AAA GTT ACA TTA AAT TCA GCA GCC TTG TTA CAA 778 Lys Phe Lys Val Thr Leu Asn Ser Ala Ala Leu Leu Gin 250 255 CGA TAT CGT GTA AGA ATA CGC TAT GCT TCT ACC ACT AAC 817 Arg Tyr Arg Val Arg lie Arg Tyr Ala Ser Thr Thr Asn 260 265 270 TTA CGA CTT TTT GTG CAA AAT TCA AAC AAT GAT TTT CTT 856 Leu Arg Leu Phe Val Gin Asn Ser Asn Asn Asp Phe Leu 275 280 285 GTC ATC TAC ATT AAT AAA ACT ATG AAT AAA GAT GAT GAT 895 Val He Tyr He Asn Lys Thr MET Asn Lys Asp Asp Asp 290 295 TTA ACA TAT CAA ACA TTT GAT CTC GCA ACT ACT AAT TCT 934 Leu Thr Tyr Gin Thr Phe Asp Leu Ala Thr Thr Asn Ser 300 305 310 AAT ATG GGG TTC TCG GGT GAT AAG AAT GAA CTT ATA ATA 973 Asn MET Gly Phe Ser Gly Asp Lys Asn Glu Leu He He 315 320 GGA GCA GAA TCT TTC GTT TCT AAT GAA AAA ATC TAT ATA 1012 Gly Ala Glu Ser Phe Val Ser Asn Glu Lys He Tyr He 325 330 335 GAT AAG ATA GAA TTT ATC CCA GTA CAA TTG TAA GGAGATTTTA 1055 Asp Lys He Glu Phe He Pro Val Gin Leu . 340 345 AAATGTTGGG TGATGGTCAA AATGAAAGAA TAGGAAGGTG AATTTTGATG 1105 GTTAGGAAAG ATTCTTTTAA CAAAAGCAAC ATGGAAAAGT ATACAGTACA 1155 AATATTAGAA ATAAAATTTA TTAACACAGG GGAAGATGGT AAACCAGAAC 1205 CGTATGGTTA TATTGACTTT TATTATCAAC CTGCTCCTAA CCTGAGAGAA 1255 GAAAAAGTAA GAATTTGGGA AGAGGAAAAT AGTAGC 1291

Claims: Claims 1. The BtI109P strain or the BtI260 strain, particularly in purified form, quite particularly 90.0 to 99.9% pure cells of the BtI109P or the BtI260 strain. 2. The BtI109P or BtI260 crystals, crystal proteins, protoxin or toxin. 3. The btI109P gene, the btI260 gene, the insecticidally effective btI109P or btI260 gene part, the truncated btI109P or btI260 gene, the btI109P or btI260 chimaeric gene or a hybrid thereof with a selectable marker gene, such as the neo gene. 4. An insecticidal composition, particularly against Coleoptera, which comprises an active ingredient selected from the group consisting of: the BtI109P or BtI260 strain, crystals, crystal proteins, protoxin and toxin and insecticidally effective portions of the BtI109P or BtI260 protoxin. 5. A transformed microorganism, particularly E. coli, characterized by the gene, the gene part, the truncated gene, the chimaeric gene or the hybrid of claim 3. 6. A transformed plant cell or a culture thereof, characterized by the insecticidally effective btI109P or btI260 gene part, the truncated btI109P or btI260 gene, the btI109P or btI260 chimaeric gene, or a hybrid thereof with a selectable marker gene, such as the neo gene. 7. A plant or a seed thereof consisting of the plant cell of claim 6. 8. A plant genome containing, integrated therein, the gene part, the truncated gene, the chimaeric gene or the hybrid of claim 6. 9. A plant tissue, the cells of which have the plant genome of claim 8. 10. A process for rendering a plant resistant to Coleoptera characterized by: providing the plant with the plant genome of claim 8. 11. In a process for producing plants and reproduction material, such as seeds, of said plants including a heterologous genetic material stably integrated in the genome thereof and capable of being expressed therein in the form of a protein toxic to insects, comprising the non-biological steps of: a) producing transformed plants cells or plant tissue including said heterologous genetic material from starting plant cells or plant tissue not expressing said protein, b) producing regenerated plants or reproduction material of said plants or both from said transformed plant cells or plant tissue including said heterologous genetic material, and c) optionally, biologically replicating said regenerated plants or reproduction material or both; wherein said step of producing said transformed plant cells or plant tissue including said heterologous genetic material is characterized by transforming said starting plant cells or plant tissue with the gene part, the truncated gene or the hybrid of claim 6 as well as regulatory elements which are capable of enabling the expression of the gene part, the truncated gene or the hybrid in said plant cells or plant tissue, to cause the stable integration of the gene part, the truncated gene or the hybrid in transformed plant cells or plant tissue, as well as in said plants and reproduction material produced therefrom throughout generations. 12. A process for controlling an insect pest, especially, Coleoptera, particularly Leptinotarsa decemlineata, Agelastica alni, Diabrotica luteola, Haltica tombacina Anthonomus grandis, Tenebrio molitor, Diabrotica undecimpunctata, Triboleu castaneum. Dicladispa armiqera, Trichispa serica, Oulema oryzae, Colaspis brunnea, Lissorhorptrus oryzophilus, Phyllotreta cruciferae, Phyllotreta striolata, Psylliodes punctulata, Entomoscelis americana, Meliqethes aeneus, Ceutorynchus sp. , Psylliodes chrysocephala, and Phyllotreta undulata characterized by contacting the pest with the insecticidal composition of claim 4. 13. A B. thurinqiensis transformed, preferably by electroporation, with the gene, the gene part or the truncated gene of claim 3. 14. A method of producing a crystal, crystal protein, protoxin or toxin of claim 2, characterized by the steps of culturing the BtI109P or BtI260 strain and, optionally, then isolating and purifying the crystal and, optionally, then isolating and purifying the protoxin from the crystal and, optionally, then trypsin digesting the protoxin to form the toxin.

Inventors: AUDENHOVE KATRIEN VAN, LAMBERT BART, PEFEROEN MARNIX, LAMBERT, BART, PEFEROEN, MARNIX, VAN ANDENHOVE, KATRIEN
Applicants: PLANT GENETIC SYSTEMS NV, PLANT GENETIC SYSTEMS N.V.
Application year: 1991
Main classification: C12N15
IPC codes: A01H1, A01H5, A01N37, A01N63, C07K14, C12N1, C12N5, C12N15, C12P21, C12R1